Penumbra jumps on Boston Scientific's $14.5 billion buyout deal
** Shares of medical equipment maker Penumbra PEN.N rise 13.6% to $356 premarket ** Boston Scientific BSX.N says it will buy Penumbra in a deal valued at about $14.5 billion ** The transaction values each Penumbra share at $374, a premium of 19.3% to the stock's last close ** The deal is expected to be completed later this year ** PEN shares rose 29.6% in 2025 (Reporting by Christy Santhosh) ((Christy.Santhosh@thomsonreuters.com))
Recent news on Penumbra
See all newsPenumbra Inc reports results for the quarter ended June 30 - Earnings Summary
Penumbra Q2 revenue slightly beats estimates, helped by product segment increase
Brief: Penumbra Q2 Revenue USD 390.046 Million Vs. IBES Estimate USD 389 Million
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Factbox: Major deals involving US drugmakers and biotechs over the past decade